Donald Healey
Directeur Technique/Scientifique/R&D chez ADICET BIO, INC.
Fortune : 63 764 $ au 30/04/2024
Provenance du réseau au premier degré de Donald Healey
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.
10
| Extinct | Pharmaceuticals: Major | 10 |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Donald Healey via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| REPROS THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | General Counsel | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Abingworth Bioventures VI LP
 Abingworth Bioventures VI LP Investment ManagersFinance Abingworth Bioventures VI LP invests in private and public companies located the US and Europe. The fund targets companies operating in the fields of medical devices, instrumentation, bio therapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, diagnostics and software. The fund provides financing for seed, early and late stage capital requirements with an investment size of $15 - $30 million. It seeks Majority or minority investments in the companies. | Investment Managers | Director/Board Member | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Analyst | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
| Texas A&M University | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Graduate Degree | |
| Indian Institute of Technology New Delhi | College/University | Undergraduate Degree Graduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Investor Relations Contact | |
Synergos, Inc.
 Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Synergos, Inc. provides clinical trial management services. The company is based in The Woodlands, TX. The company was founded by Jaye L. Thompson. Synergos was acquired by Ventiv Health, Inc. on April 05, 2006 for $5.75 million. | Miscellaneous Commercial Services | Founder | |
HSBC Bank Plc (Broker)
 HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
| ACUCELA INC | Pharmaceuticals: Major | General Counsel | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Texas University of Health Center at San Antonio | College/University | Doctorate Degree | |
| inVentiv Clinical Solutions LLC | General Counsel | ||
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Alliance for Cancer Gene Therapy, Inc.
 Alliance for Cancer Gene Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Alliance for Cancer Gene Therapy, Inc. provides funding for cancer research. The non-profit company is based in Stamford, CT. The company was founded by Edward Netter. Kevin Honeycutt has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Gulf Coast Regional Center of Innovation & Commercialization | Director/Board Member | ||
| Lifetecnet | Director of Finance/CFO | ||
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Proxima Clinical Research, Inc.
 Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Clinical Research, Inc. is a contract research organization that provides regulatory and clinical research expertise to life sciences companies of all sizes and stages. The private company is based in Houston, TX, within the Texas Medical Center, the largest medical center in the world. Proxima CRO partners with medical device, pharmaceutical, biotechnology, and diagnostic firms across 18 countries and five continents to further advance the $130 billion industry. The company was founded by Kevin Coker, Jaye L. Thompson, Larry Wayne Lawson, and Kevin Coker has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| GREENWICH LIFESCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 41 |
| Royaume-Uni | 6 |
| Canada | 3 |
| Israël | 2 |
| Inde | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Finance | 8 |
Opérationnelle
| Director/Board Member | 217 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 61 |
| Chief Executive Officer | 33 |
| President | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Erez Chimovits | 30 |
| Steve Dubin | 25 |
| David Hung | 24 |
| Michael Kauffman | 24 |
| Chen Schor | 23 |
| Timothy Barabe | 21 |
| Gail Maderis | 20 |
| Yair Schindel | 16 |
| Aya Jakobovits | 16 |
| Jeffrey Chodakewitz | 15 |
| Andrew Sinclair | 14 |
| Scott B. Seaman | 12 |
| Brian Harvey | 11 |
| Nancy L. Boman | 10 |
- Bourse
- Insiders
- Donald Healey
- Connexions Sociétés
